Wed, June 12, 2013
Tue, June 11, 2013
Mon, June 10, 2013
Fri, June 7, 2013
Thu, June 6, 2013
Wed, June 5, 2013
Tue, June 4, 2013
Mon, June 3, 2013
Fri, May 31, 2013
Thu, May 30, 2013
Wed, May 29, 2013
Tue, May 28, 2013
Fri, May 24, 2013
Thu, May 23, 2013
Wed, May 22, 2013
Tue, May 21, 2013

Andrew Peters Upgraded (BMRN) to Strong Buy and Held Target at $75 on, Jun 3rd, 2013

Andrew Peters of Deutsche Bank, Upgraded "BioMarin Pharmaceutical Inc." (BMRN) to Strong Buy and Held Target at $75 on, Jun 3rd, 2013.

Andrew has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $70 on, Wednesday, March 20th, 2013
  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $71 on, Tuesday, February 12th, 2013


Similar Stocks and Investing Publications